Funds

Our portfolio is managed through a series of funds. Fund IV, focusing solely on therapeutics, is actively
pursuing new investment opportunities.

Funds

Portfolio companies

Million € invested

Million € returned to investors

Sunstone Life Science Ventures Fund I

Sunstone Life Science Ventures Fund I was established at the inception of Sunstone in 2007. The total committed capital is EUR 200 million. The investment strategy included therapeutics, medical technology and diagnostics. The fund is no longer making new investments.

Sunstone Life Science Ventures Fund II

Sunstone Life Science Ventures Fund II was established at the inception of Sunstone in 2007. The total committed capital is EUR 86 million and the fund invested in 12 new portfolio companies. The investment strategy included therapeutics, medical technology and diagnostics. The fund is no longer making new investments.

Sunstone Biomedical Ventures Fund I-III

In 2010, Sunstone took over management of the former BankInvest Biotechnology Funds. The funds are no longer making new investments.

Sunstone Life Science Ventures Fund III

Sunstone Life Science Ventures Fund III was established in 2012. The total committed capital is EUR 80 million and the fund invested in 11 new portfolio companies. The investment strategy included therapeutics, and medical technology. The fund is no longer making new investments.

Sunstone Life Science Ventures Fund IV

Sunstone Life Science Ventures Fund IV was established 2019. The fund had first close at EUR 80 million and is currently fundraising aiming at a total of EUR 120 million in committed capital. The investment strategy is focused entirely on therapeutics. The fund is currently building the portfolio and is actively pursuing new investment opportunities.